What is Cencora, Inc.'s earnings per share (EPS)?

Cencora, Inc. (COR) reported diluted earnings per share of $7.96 for fiscal year 2025. This represents a 5.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cencora, Inc. (COR) Financials

COR

Trailing 12 months to June 30, 2026

Revenue $332.8B +5.1% YoY

Net Income $2.6B +38.3% YoY

EPS (Diluted) $13.47 +38.3% YoY

Free Cash Flow $4.1B +255.7% YoY

Market Cap $60.5B as of Oct 8, 2026

Price / Sales 0.2x on $332.8B revenue, trailing 12 months to June 30, 2026

Price / Earnings 23.1x on $2.6B net income, trailing 12 months to June 30, 2026

Price / Book 19.8x on $3.1B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the COR SEC filings page.

Cencora, Inc. (COR) reported $332.8B in revenue over the twelve months to Jun 30, 2026, up 5.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI COR FY2025 2026-10-04

Cencora scales enormous sales through a thin-margin distribution model, making cash conversion and balance-sheet funding central to how it operates.

FY2025 combined revenue of $321B with a gross margin of 3.6%, indicating that margin expansion, not just volume, lifted gross profit. Operating cash flow of $3.9B exceeded net income of $1.6B, while free cash flow reached $3.2B; cash generation is shaped by more than reported profit alone.

Liquidity is structurally tight at the operating level: current assets were below current liabilities, reflected in a current ratio of 0.9x, leaving only a modest short-term cushion. Debt-to-equity was 5.0x even after equity turned positive, showing that the improved equity cushion remains small relative to debt.

FY2025 capital spending of $668M consumed only part of operating cash flow, leaving $3.2B of free cash flow; the model is therefore not heavily reinvestment-intensive despite its enormous sales base. Yet operating margin was only 0.8%, so cash generation depends more on transaction volume than on retaining much profit per sale.

Financial Health Signals

Financial Health Score 50/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cencora, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Cencora, Inc. has an operating margin of 0.8%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 53/100, indicating healthy but not exceptional operating efficiency. This is up from 0.7% the prior year.

Growth

Cencora, Inc.'s revenue grew 9.3% year-over-year to $321.3B, a solid pace of expansion. This earns a growth score of 67/100.

Leverage

Cencora, Inc. has a moderate D/E ratio of 5.00. This balance of debt and equity financing earns a leverage score of 50/100.

Liquidity

Cencora, Inc.'s current ratio of 0.90 is below the typical benchmark, resulting in a score of 15/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Cencora, Inc.'s free cash flow margin of 1.0% results in a low score of 29/100. Capital expenditures of $668.0M absorb a large share of operating cash flow.

Returns

Cencora, Inc. earns a strong 103.1% return on equity (ROE), meaning it generates $103 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 86/100. This is down from 233.6% the prior year.

Altman Z-Score Safe

4.82

Cencora, Inc. scores 4.82, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

Cencora, Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

2.49x

For every $1 of reported earnings, Cencora, Inc. generates $2.49 in operating cash flow ($3.9B OCF vs $1.6B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

9.02x

Cencora, Inc. earns $9.02 in operating income for every $1 of interest expense ($2.6B vs $291.5M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$84.8B

YoY+5.1%

QoQ+8.2%

5Y CAGR+9.7%

10Y CAGR+8.7%

Cencora, Inc. generated $84.8B in revenue in Q3 2026. This represents an increase of 5.1% from the same quarter a year earlier. Against the prior quarter it is up 8.2%.

EBITDA

$1.4B

YoY+23.9%

QoQ-0.2%

5Y CAGR+13.2%

Cencora, Inc.'s EBITDA was $1.4B in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 23.9% from the same quarter a year earlier. Against the prior quarter it is down 0.2%.

Net Income

$763.5M

YoY+11.1%

QoQ-53.5%

5Y CAGR+21.2%

10Y CAGR+8.1%

Cencora, Inc. reported $763.5M in net income in Q3 2026. This represents an increase of 11.1% from the same quarter a year earlier. Against the prior quarter it is down 53.5%.

EPS (Diluted)

$3.94

YoY+11.9%

QoQ-53.1%

5Y CAGR+23.0%

10Y CAGR+9.8%

Cencora, Inc. earned $3.94 per diluted share (EPS) in Q3 2026. This represents an increase of 11.9% from the same quarter a year earlier. Against the prior quarter it is down 53.1%.

Cash & Balance Sheet

Free Cash Flow

$2.4B

YoY+3382.5%

QoQ+107.0%

5Y CAGR+17.5%

10Y CAGR+44.4%

Cencora, Inc. generated $2.4B in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 3382.5% from the same quarter a year earlier. Against the prior quarter it is up 107.0%.

Cash & Debt

$2.8B

YoY+26.1%

QoQ+29.3%

5Y CAGR+2.0%

10Y CAGR+4.2%

Cencora, Inc. held $2.8B in cash against $11.4B in long-term debt as of Q3 2026.

Dividends Per Share

$0.60

YoY+9.1%

QoQ0.0%

5Y CAGR+6.4%

10Y CAGR+5.8%

Cencora, Inc. paid $0.60 per share in dividends in Q3 2026. This represents an increase of 9.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

191M

YoY-1.6%

QoQ-1.9%

5Y CAGR-1.7%

10Y CAGR-1.2%

Cencora, Inc. had 191M shares outstanding in Q3 2026. This represents a decrease of 1.6% from the same quarter a year earlier. Against the prior quarter it is down 1.9%.

Margins & Returns

Gross Margin

4.3%

YoY+0.7pp

QoQ-0.3pp

5Y change+0.7pp

10Y change+1.3pp

Cencora, Inc.'s gross margin was 4.3% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.3 percentage points.

Operating Margin

1.3%

YoY+0.2pp

QoQ-0.1pp

5Y change+0.2pp

10Y change-0.1pp

Cencora, Inc.'s operating margin was 1.3% in Q3 2026, reflecting core business profitability. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Net Margin

0.9%

YoY0.0pp

QoQ-1.2pp

5Y change+0.3pp

10Y change-0.1pp

Cencora, Inc.'s net profit margin was 0.9% in Q3 2026, showing the share of revenue converted to profit. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 1.2 percentage points.

Return on Equity

25.0%

YoY-9.7pp

QoQ-23.3pp

Cencora, Inc.'s ROE was 25.0% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 9.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 23.3 percentage points.

Capital Allocation

Share Buybacks

$1.0B

10Y CAGR+5.5%

Cencora, Inc. spent $1.0B on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$226.0M

YoY+23.4%

QoQ+36.5%

5Y CAGR+13.2%

10Y CAGR+5.7%

Cencora, Inc. invested $226.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 23.4% from the same quarter a year earlier. Against the prior quarter it is up 36.5%.

R&D Spending

Not reported for Q3 2026.

COR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

COR quarterly income statement

Metric	TTM	FY258-K	FY248-K	FY238-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$332.8B	$321.3B+9.3%	$294.0B+12.1%	$262.2B+9.9%	$238.6B+11.5%	$214.0B+12.7%	$189.9B+5.7%	$179.6B+6.9%	$167.9B+9.7%	$153.1B+4.3%	$146.8B+8.0%	$136.0B+13.7%	$119.6B+35.9%	$88.0B+12.7%	$78.1B-0.8%	$78.7B
Cost of Revenue	$319.6B	$309.9B+9.1%	$284.0B+12.2%	$253.2B+10.0%	$230.3B+11.2%	$207.0B+12.1%	$184.7B+5.9%	$174.5B+6.8%	$163.3B+9.9%	$148.6B+4.2%	$142.6B+7.7%	$132.4B+13.6%	$116.6B+36.4%	$85.5B+13.3%	$75.4B-1.0%	$76.2B
Gross Profit	$13.2B	$11.5B+15.8%	$9.9B+10.6%	$9.0B+8.0%	$8.3B+19.5%	$6.9B+33.7%	$5.2B+1.0%	$5.1B+11.4%	$4.6B+1.5%	$4.5B+6.4%	$4.3B+21.1%	$3.5B+18.3%	$3.0B+18.9%	$2.5B-4.8%	$2.6B+7.1%	$2.5B
SG&A Expenses	$7.7B	$6.5B+14.7%	$5.7B+6.6%	$5.3B+9.5%	$4.8B+34.9%	$3.6B+29.9%	$2.8B+3.9%	$2.7B+8.3%	$2.5B+15.6%	$2.1B+1.8%	$2.1B+9.6%	$1.9B+20.7%	$1.6B+18.5%	$1.3B+15.7%	$1.2B+1.3%	$1.1B
Operating Income	$3.0B	$2.6B+20.8%	$2.2B-7.1%	$2.3B-1.1%	$2.4B+0.5%	$2.4B+145.8%	-$5.1B-561.8%	$1.1B-23.0%	$1.4B+36.2%	$1.1B-30.5%	$1.5B+261.4%	$422.2M-46.0%	$782.1M-12.9%	$898.4M-31.1%	$1.3B+9.6%	$1.2B
EBITDA	N/A	$3.7B+12.6%	$3.3B-1.1%	$3.3B+8.0%	$3.1B+7.0%	$2.9B+160.3%	-$4.7B-401.4%	$1.6B-17.5%	$1.9B+30.9%	$1.5B-22.9%	$1.9B+181.8%	$670.9M-30.9%	$970.8M-8.5%	$1.1B-26.2%	$1.4B+11.4%	$1.3B
Interest Expense	$431.4M	$291.5M+85.7%	$157.0M-31.4%	$228.9M+8.7%	$210.7M+21.0%	$174.1M+26.2%	$137.9M-12.6%	$157.8M-9.7%	$174.7M+20.3%	$145.2M+3.8%	$139.9M+28.3%	$109.0M+30.4%	$83.6M+13.2%	$73.9M+179.8%	-$92.6M-21.6%	-$76.1M
Income Tax	$967.3M	$690.5M+42.5%	$484.7M+13.2%	$428.3M-17.1%	$516.5M-23.7%	$677.3M+135.8%	-$1.9B-1776.8%	$113.0M+125.8%	-$438.5M-179.2%	$553.4M+1594.9%	-$37.0M-109.1%	$407.1M+4.9%	$388.1M+17.2%	$331.0M-27.3%	$455.5M+8.3%	$420.5M
Net Income	$2.6B	$1.6B+3.0%	$1.5B-13.5%	$1.7B+2.7%	$1.7B+10.3%	$1.5B+145.2%	-$3.4B-498.5%	$855.4M-48.4%	$1.7B+355.0%	$364.5M-74.5%	$1.4B+1133.5%	-$138.2M-150.4%	$274.2M-36.8%	$433.7M-39.7%	$719.0M+1.7%	$706.6M
EPS (Basic)	N/A	$8.02+5.5%	$7.60-11.8%	$8.62+5.8%	$8.15+9.0%	$7.48+144.9%	-$16.65-509.1%	$4.07-46.5%	$7.61+355.7%	$1.67-75.2%	$6.73+1168.3%	-$0.63-152.1%	$1.21-35.6%	$1.88-33.8%	$2.84+9.7%	$2.59
EPS (Diluted)	$13.47	$7.96+5.7%	$7.53-11.7%	$8.53+6.1%	$8.04+8.8%	$7.39+144.4%	-$16.65-512.1%	$4.04-46.3%	$7.53+359.1%	$1.64-74.1%	$6.32+1103.2%	-$0.63-154.3%	$1.16-37.0%	$1.84-34.3%	$2.80+10.2%	$2.54
Diluted Shares (Avg)	N/A	195M-2.5%	200M-2.1%	205M-3.1%	211M+1.3%	208M+1.8%	205M-3.3%	212M-3.9%	220M-0.6%	222M-1.9%	226M+3.8%	218M-7.5%	235M+99925.5%	235,345-99.9%	257M-7.5%	278M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'248-K
Revenue	$84.8B+5.1%	$78.4B+3.8%	$85.9B+5.5%	$83.7B+5.9%	$80.7B+8.7%	$75.5B+10.3%	$81.5B+12.8%	$79.1B+14.7%
Cost of Revenue	$81.1B+4.4%	$74.8B+3.3%	$82.9B+5.0%	$80.8B+5.5%	$77.8B+8.2%	$72.4B+9.9%	$78.9B+13.1%	$76.6B+14.8%
Gross Profit	$3.6B+24.1%	$3.6B+17.3%	$3.1B+20.1%	$3.0B+18.5%	$2.9B+20.6%	$3.1B+20.6%	$2.6B+3.6%	$2.5B+10.6%
SG&A Expenses	$2.1B+27.5%	$2.0B+23.6%	$1.8B+22.0%	$1.7B+17.3%	$1.7B+20.9%	$1.6B+15.2%	$1.5B+5.2%	$1.5B+6.9%
Operating Income	$1.1B+29.1%	$1.1B+10.3%	$760.4M+7.7%	$18.5M-85.4%	$867.7M+29.0%	$1.0B+87.3%	$706.3M-14.2%	$126.6M-73.4%
EBITDA	$1.4B+23.9%	$1.4B+7.4%	$1.0B+3.7%	$277.3M-28.0%	$1.1B+17.9%	$1.3B+55.9%	$984.7M-10.4%	$385.1M-48.7%
Interest Expense	$140.7M+72.0%	$140.5M+35.1%	$72.4M+159.2%	$77.8M+271.2%	$81.8M+161.1%	$104.0M+62.2%	$27.9M-31.1%	$21.0M-65.6%
Income Tax	$219.7M+6.4%	$459.0M+117.3%	$142.5M+12.5%	$146.0M+24.1%	$206.5M+46.7%	$211.2M+360.6%	$126.7M-29.7%	$117.7M+20.8%
Net Income	$763.5M+11.1%	$1.6B+128.6%	$559.6M+14.5%	-$339.7M-10144.5%	$687.4M+42.2%	$717.9M+70.6%	$488.6M-18.8%	$3.4M-99.0%
EPS (Basic)	$3.95+11.3%	$8.44+128.1%	$2.88+14.3%	-$1.75-4475.0%	$3.55+45.5%	$3.70+75.4%	$2.52-16.3%	$0.04-97.7%
EPS (Diluted)	$3.94+11.9%	$8.40+128.3%	$2.87+14.8%	-$1.74	$3.52+45.5%	$3.68+76.1%	$2.50-16.1%	$0.04
Diluted Shares (Avg)	194M-0.7%	195M+0.1%	195M+0.1%	N/A	195M-2.4%	195M-3.0%	195M-3.3%	N/A

Not reported in any period shown, so not listed: R&D Expenses.

COR Balance Sheet

COR quarterly balance sheet

Metric	FY258-K	FY248-K	FY238-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$76.6B+14.1%	$67.1B+7.3%	$62.6B+10.6%	$56.6B-1.4%	$57.3B+29.5%	$44.3B+13.0%	$39.2B+4.0%	$37.7B+6.7%	$35.3B+5.0%	$33.6B+20.3%	$28.0B+29.9%	$21.5B+13.8%	$18.9B+22.5%	$15.4B+3.1%	$15.0B
Current Assets	$52.2B+9.5%	$47.7B+11.5%	$42.8B+8.1%	$39.6B+2.0%	$38.8B+17.4%	$33.1B+17.5%	$28.1B+8.6%	$25.9B+6.5%	$24.3B+6.4%	$22.9B+12.4%	$20.3B+21.0%	$16.8B+16.7%	$14.4B+30.2%	$11.1B-3.1%	$11.4B
Cash & Equivalents	$4.4B+39.1%	$3.1B+20.9%	$2.6B-23.5%	$3.4B+33.0%	$2.5B-44.6%	$4.6B+36.3%	$3.4B+35.4%	$2.5B+2.4%	$2.4B-11.2%	$2.7B+26.5%	$2.2B+19.8%	$1.8B+46.9%	$1.2B+15.4%	$1.1B-41.6%	$1.8B
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$20.5B+7.9%	$19.0B+8.8%	$17.5B+12.2%	$15.6B+1.2%	$15.4B+22.1%	$12.6B+13.8%	$11.1B-7.2%	$11.9B+4.0%	$11.5B+6.9%	$10.7B+9.9%	$9.8B+13.5%	$8.6B+23.1%	$7.0B+27.6%	$5.5B+2.9%	$5.3B
Accounts Receivable	$25.2B+5.7%	$23.9B+14.2%	$20.9B+13.3%	$18.5B+1.6%	$18.2B+31.2%	$13.8B+11.8%	$12.4B+9.5%	$11.3B+9.8%	$10.3B+12.3%	$9.2B+11.6%	$8.2B+30.3%	$6.3B+4.3%	$6.1B+59.9%	$3.8B+3.0%	$3.7B
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$13.7B+46.8%	$9.3B-2.7%	$9.6B+12.6%	$8.5B-5.8%	$9.0B+34.6%	$6.7B0.0%	$6.7B+0.6%	$6.7B+10.3%	$6.0B+0.9%	$6.0B+44.6%	$4.1B+40.6%	$2.9B+0.1%	$2.9B+0.1%	$2.9B+17.9%	$2.5B
Total Liabilities	$75.1B+13.0%	$66.5B+7.1%	$62.0B+9.3%	$56.8B-0.6%	$57.1B+26.1%	$45.3B+24.8%	$36.3B+4.5%	$34.7B+4.5%	$33.3B+5.5%	$31.5B+15.2%	$27.3B+39.6%	$19.6B+17.9%	$16.6B+27.9%	$13.0B+7.2%	$12.1B
Current Liabilities	$57.8B+6.5%	$54.3B+11.2%	$48.8B+12.3%	$43.5B+5.1%	$41.4B+22.2%	$33.9B+14.4%	$29.6B+6.1%	$27.9B+3.9%	$26.8B+6.1%	$25.3B+17.2%	$21.6B+25.1%	$17.3B+16.0%	$14.9B+32.0%	$11.3B+3.4%	$10.9B
Non-Current Liabilities	$17.3B+41.7%	$12.2B-7.8%	$13.2B-0.7%	$13.3B-15.6%	$15.8B+37.7%	$11.4B+70.5%	$6.7B-2.3%	$6.9B+6.7%	$6.4B+3.3%	$6.2B+8.0%	$5.8B+146.6%	$2.3B+34.4%	$1.7B+1.0%	$1.7B+41.4%	$1.2B
Long-Term Debt	$7.5B+97.9%	$3.8B-8.1%	$4.1B-10.5%	$4.6B-27.4%	$6.4B+76.4%	$3.6B-10.3%	$4.0B-3.0%	$4.2B+21.2%	$3.4B-4.1%	$3.6B+2.4%	$3.5B+75.0%	$2.0B+42.9%	$1.4B0.0%	$1.4B+46.8%	$951.0M
Total Equity	$1.5B+133.5%	$645.9M+23.7%	$522.0M+346.7%	-$211.6M-194.7%	$223.4M+121.9%	-$1.0B-135.4%	$2.9B-1.8%	$2.9B+42.1%	$2.1B-3.0%	$2.1B+245.5%	$616.4M-68.3%	$1.9B-15.8%	$2.3B-6.0%	$2.5B-14.4%	$2.9B
Retained Earnings	$6.5B+20.6%	$5.4B+25.3%	$4.3B+45.2%	$3.0B+78.2%	$1.7B+222.3%	$518.3M-87.8%	$4.2B+13.8%	$3.7B+55.3%	$2.4B+4.0%	$2.3B+97.8%	$1.2B-25.8%	$1.6B+4.1%	$1.5B+18.7%	$1.3B-68.7%	$4.1B

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'248-K
Total Assets	$83.8B+13.3%	$81.7B+14.7%	$78.4B+13.5%	$76.6B+14.1%	$74.0B+10.8%	$71.2B+11.5%	$69.1B+6.7%	$67.1B+7.3%
Current Assets	$55.3B+13.4%	$53.1B+14.2%	$54.2B+8.3%	$52.2B+9.5%	$48.8B+3.2%	$46.5B+5.4%	$50.0B+11.4%	$47.7B+11.5%
Cash & Equivalents	$2.8B+26.1%	$2.2B+10.0%	$1.8B-45.6%	$4.4B+39.1%	$2.2B-32.5%	$2.0B-4.4%	$3.2B+12.3%	$3.1B+20.9%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$21.0B+4.4%	$20.0B+5.5%	$24.1B+17.4%	$20.5B+7.9%	$20.1B+10.0%	$19.0B+7.6%	$20.5B+9.9%	$19.0B+8.8%
Accounts Receivable	$25.4B+3.6%	$24.9B+5.0%	$26.0B+5.8%	$25.2B+5.7%	$24.6B+2.1%	$23.7B+4.7%	$24.5B+13.8%	$23.9B+14.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$16.5B+15.3%	$16.5B+16.8%	$13.7B+49.6%	$13.7B+46.8%	$14.3B+49.0%	$14.1B+46.5%	$9.2B-5.0%	$9.3B-2.7%
Total Liabilities	$80.8B+12.2%	$78.3B+11.5%	$76.5B+11.1%	$75.1B+13.0%	$72.0B+9.3%	$70.2B+11.8%	$68.8B+7.9%	$66.5B+7.1%
Current Liabilities	$59.2B+9.7%	$56.1B+5.3%	$59.1B+8.5%	$57.8B+6.5%	$54.0B+1.9%	$53.3B+7.2%	$54.5B+7.4%	$54.3B+11.2%
Non-Current Liabilities	$21.6B+19.6%	$22.1B+31.3%	$17.3B+21.0%	$17.3B+41.7%	$18.0B+40.0%	$16.9B+29.4%	$14.3B+10.1%	$12.2B-7.8%
Long-Term Debt	$11.4B+42.3%	$12.2B+71.9%	$7.6B+27.7%	$7.5B+97.9%	$8.0B+93.1%	$7.1B+69.5%	$5.9B+41.8%	$3.8B-8.1%
Total Equity	$3.1B+54.1%	$3.4B+235.5%	$1.9B+742.2%	$1.5B+133.5%	$2.0B+114.0%	$1.0B-6.5%	$226.6M-75.1%	$645.9M+23.7%
Retained Earnings	$9.1B+30.9%	$8.5B+32.6%	$7.0B+20.2%	$6.5B+20.6%	$7.0B+26.6%	$6.4B+24.7%	$5.8B+20.2%	$5.4B+25.3%

COR Cash Flow Statement

COR quarterly cash flow statement

Metric	TTM	FY258-K	FY248-K	FY238-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$4.8B	$3.9B+11.2%	$3.5B-10.9%	$3.9B+44.7%	$2.7B+1.4%	$2.7B+20.8%	$2.2B-5.8%	$2.3B+66.1%	$1.4B-6.2%	$1.5B-52.7%	$3.2B-19.0%	$3.9B+167.8%	$1.5B+85.8%	$788.1M-39.6%	$1.3B+11.8%	$1.2B
Depreciation & Amortization	N/A	$1.1B-3.7%	$1.1B+13.3%	$963.9M+38.9%	$693.9M+37.4%	$505.2M+29.2%	$391.1M-15.4%	$462.4M-0.6%	$465.1M+17.0%	$397.6M+9.0%	$364.7M+46.7%	$248.6M+31.8%	$188.7M+16.3%	$162.2M+20.7%	$134.4M+32.6%	$101.4M
Stock-Based Compensation	N/A	$148.0M0.0%	$148.0M+18.8%	$124.6M+33.4%	$93.4M-6.2%	$99.6M+33.8%	$74.4M+26.4%	$58.9M-5.5%	$62.3M+0.2%	$62.2M-4.3%	$65.0M+6.6%	$60.9M+41.4%	$43.1M+18.8%	$36.3M+39.8%	$26.0M-4.9%	$27.3M
Capital Expenditures	$760.8M	$668.0M+37.1%	$487.2M+6.3%	$458.4M-7.6%	$496.3M+13.3%	$438.2M+18.5%	$369.7M+19.2%	$310.2M-7.8%	$336.4M-27.9%	$466.4M+0.4%	$464.6M+100.6%	$231.6M-12.4%	$264.5M+30.6%	$202.4M+51.9%	$133.3M-14.6%	$156.1M
Free Cash Flow	$4.1B	$3.2B+7.0%	$3.0B-13.2%	$3.5B+56.5%	$2.2B-1.0%	$2.2B+21.3%	$1.8B-9.7%	$2.0B+89.2%	$1.1B+3.6%	$1.0B-61.8%	$2.7B-26.5%	$3.7B+207.5%	$1.2B+104.9%	$585.7M-50.0%	$1.2B+15.8%	$1.0B
Investing Cash Flow	-$5.7B	-$5.0B-705.3%	-$618.1M+76.2%	-$2.6B-606.4%	-$368.4M+94.0%	-$6.1B-1516.8%	-$379.9M-1.1%	-$375.8M+66.2%	-$1.1B-123.1%	-$498.0M+84.3%	-$3.2B-8.1%	-$2.9B-663.0%	-$384.2M-427.6%	$117.3M+112.4%	-$947.9M-346.3%	-$212.4M
Financing Cash Flow	$1.6B	$2.2B+196.5%	-$2.3B-4.9%	-$2.2B-26.8%	-$1.8B-189.8%	$2.0B+423.5%	-$603.6M+44.4%	-$1.1B-347.4%	-$242.9M+81.5%	-$1.3B-332.3%	$565.1M+189.4%	-$632.1M-25.7%	-$503.0M+32.1%	-$741.0M+33.7%	-$1.1B-41.8%	-$787.7M
Dividends Paid	$468.1M	$437.1M+5.0%	$416.2M+4.4%	$398.8M+1.8%	$391.7M+6.8%	$366.6M+6.7%	$343.6M+1.4%	$339.0M+1.8%	$333.0M+4.0%	$320.3M+11.0%	$288.5M+13.6%	$253.9M+18.4%	$214.5M+9.6%	$195.7M+47.4%	$132.8M+12.9%	$117.6M
Share Buybacks	$1.0B	$435.5M-70.8%	$1.5B+26.3%	$1.2B+144.1%	$483.7M+488.8%	$82.2M-80.5%	$420.4M-37.6%	$674.0M+5.4%	$639.2M+93.7%	$329.9M-85.4%	$2.3B+21.9%	$1.9B+146.6%	$753.9M+55.7%	$484.2M-58.3%	$1.2B+38.3%	$840.6M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'248-K
Operating Cash Flow	$2.7B+2329.4%	$1.3B-60.1%	-$2.3B+15.2%	$3.1B+213.2%	$109.2M-95.6%	$3.4B+481.5%	-$2.7B-407.2%	$1.0B-45.2%
Depreciation & Amortization	$269.5M+6.1%	$249.3M-4.1%	$260.4M-6.5%	$258.8M+0.1%	$254.0M-8.9%	$259.8M-6.6%	$278.5M+0.7%	$258.4M-5.5%
Stock-Based Compensation	N/A	N/A	$66.1M-6.2%	N/A	N/A	N/A	$70.4M+11.6%	N/A
Capital Expenditures	$226.0M+23.4%	$165.6M+28.3%	$119.4M+12.7%	$249.8M+37.0%	$183.2M+55.4%	$129.1M+14.5%	$105.9M+42.7%	$182.3M+3.9%
Free Cash Flow	$2.4B+3382.5%	$1.2B-63.6%	-$2.4B+14.2%	$2.9B+252.5%	-$74.0M-103.1%	$3.2B+425.1%	-$2.8B-448.3%	$818.1M-50.5%
Investing Cash Flow	-$240.1M-2.3%	-$4.9B-19.6%	-$299.3M+12.7%	-$321.9M-33.1%	-$234.7M-63.1%	-$4.1B-2349.2%	-$343.0M-421.3%	-$241.9M-31.9%
Financing Cash Flow	-$1.8B-920.4%	$4.0B+909.1%	$43.2M-98.7%	-$683.8M+28.6%	$215.5M+118.8%	-$491.7M-252.2%	$3.2B+681.7%	-$957.3M-135.2%
Dividends Paid	$116.6M+8.5%	$117.5M+5.6%	$126.5M+14.1%	$107.5M+6.5%	$107.5M+4.8%	$111.2M+3.9%	$110.9M+4.9%	$100.9M+2.7%
Share Buybacks	$1.0B	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%	$50.1M-1.5%	$385.4M0.0%	$505.0M+84.6%

COR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

COR quarterly financial ratios

Metric	FY258-K	FY248-K	FY238-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	3.6%+0.2pp	3.4%-0.1pp	3.4%-0.1pp	3.5%+0.2pp	3.2%+0.5pp	2.7%-0.1pp	2.9%+0.1pp	2.8%-0.2pp	3.0%+0.1pp	2.9%+0.3pp	2.6%+0.1pp	2.5%-0.4pp	2.9%-0.5pp	3.4%+0.3pp	3.1%
Operating Margin	0.8%+0.1pp	0.7%-0.1pp	0.9%-0.1pp	1.0%-0.1pp	1.1%+3.8pp	-2.7%-3.3pp	0.6%-0.2pp	0.9%+0.2pp	0.7%-0.3pp	1.0%+0.7pp	0.3%-0.3pp	0.7%-0.4pp	1.0%-0.6pp	1.7%+0.2pp	1.5%
Net Margin	0.5%0.0pp	0.5%-0.2pp	0.7%0.0pp	0.7%0.0pp	0.7%+2.5pp	-1.8%-2.3pp	0.5%-0.5pp	1.0%+0.8pp	0.2%-0.7pp	1.0%+1.1pp	-0.1%-0.3pp	0.2%-0.3pp	0.5%-0.4pp	0.9%0.0pp	0.9%
Return on Equity	103.1%-130.6pp	233.6%-100.7pp	334.4%	N/A	689.5%	N/A	29.7%-26.8pp	56.5%+38.9pp	17.7%-49.4pp	67.1%+89.5pp	-22.4%-36.5pp	14.1%-4.7pp	18.8%-10.5pp	29.3%+4.6pp	24.6%
Return on Assets	2.0%-0.2pp	2.3%-0.5pp	2.8%-0.2pp	3.0%+0.3pp	2.7%+10.4pp	-7.7%-9.9pp	2.2%-2.2pp	4.4%+3.4pp	1.0%-3.2pp	4.3%+4.7pp	-0.5%-1.8pp	1.3%-1.0pp	2.3%-2.4pp	4.7%-0.1pp	4.7%
Current Ratio	0.900.0x	0.880.0x	0.880.0x	0.910.0x	0.940.0x	0.980.0x	0.950.0x	0.930.0x	0.910.0x	0.900.0x	0.940.0x	0.970.0x	0.970.0x	0.98-0.1x	1.05
Debt-to-Equity	5.00-0.9x	5.90-2.0x	7.94	N/A	28.58	N/A	1.400.0x	1.42-0.2x	1.660.0x	1.68-4.0x	5.67+4.6x	1.03+0.4x	0.610.0x	0.57+0.2x	0.33
Asset Turnover	4.20-0.2x	4.38+0.2x	4.190.0x	4.22+0.5x	3.73-0.6x	4.29-0.3x	4.58+0.1x	4.46+0.1x	4.340.0x	4.37-0.5x	4.86-0.7x	5.55+0.9x	4.65-0.4x	5.06-0.2x	5.25
FCF Margin	1.0%0.0pp	1.0%-0.3pp	1.3%+0.4pp	0.9%-0.1pp	1.0%+0.1pp	1.0%-0.2pp	1.1%+0.5pp	0.6%0.0pp	0.7%-1.2pp	1.8%-0.9pp	2.7%+1.7pp	1.0%+0.3pp	0.7%-0.8pp	1.5%+0.2pp	1.3%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'248-K
Gross Margin	4.3%+0.7pp	4.6%+0.5pp	3.6%+0.4pp	3.5%+0.4pp	3.6%+0.3pp	4.1%+0.3pp	3.1%-0.3pp	3.1%-0.1pp
Operating Margin	1.3%+0.2pp	1.5%+0.1pp	0.9%0.0pp	0.0%-0.1pp	1.1%+0.2pp	1.4%+0.6pp	0.9%-0.3pp	0.2%-0.5pp
Net Margin	0.9%0.0pp	2.1%+1.1pp	0.7%0.0pp	-0.4%-0.4pp	0.9%+0.2pp	0.9%+0.3pp	0.6%-0.2pp	0.0%-0.5pp
Return on Equity	25.0%-9.7pp	48.3%-22.6pp	29.3%-186.3pp	-22.5%-23.0pp	34.7%-17.5pp	70.9%+32.0pp	215.6%+149.7pp	0.5%-66.6pp
Return on Assets	0.9%0.0pp	2.0%+1.0pp	0.7%0.0pp	-0.4%-0.5pp	0.9%+0.2pp	1.0%+0.3pp	0.7%-0.2pp	0.0%-0.5pp
Current Ratio	0.930.0x	0.95+0.1x	0.920.0x	0.900.0x	0.900.0x	0.870.0x	0.920.0x	0.880.0x
Debt-to-Equity	3.75-0.3x	3.59-3.4x	3.97-22.2x	5.00-0.9x	4.06-0.4x	7.00+3.1x	26.20+21.6x	5.90-2.0x
Asset Turnover	1.01-0.1x	0.96-0.1x	1.10-0.1x	1.09-0.1x	1.090.0x	1.060.0x	1.18+0.1x	1.18+0.1x
FCF Margin	2.9%+3.0pp	1.5%-2.8pp	-2.8%+0.7pp	3.4%+2.4pp	-0.1%-3.3pp	4.3%+5.7pp	-3.5%-4.6pp	1.0%-1.4pp

Note: The current ratio is below 1.0 (0.90), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Cencora, Inc. COR	FY2025	$321.3B	$1.6B	0.5%	$60.5B	50/100
McKesson Corporation MCK	FY2026	$403.4B	$4.8B	1.2%	$106.1B	55/100
Cardinal Health, Inc. CAH	FY2026	$254.2B	$1.7B	0.7%	$53.8B	44/100
Henry Schein Inc HSIC	FY2025	$13.2B	$419.0M	3.2%	$9.3B	46/100
Becton, Dickinson and Co. BDX	FY2025	$21.8B	$1.7B	7.7%	$49.1B	52/100
Edwards Lifesciences Corp EW	FY2025	$6.1B	$1.1B	17.7%	$49.4B	73/100

Where Cencora, Inc. Ranks

Frequently Asked Questions

What is Cencora, Inc.'s annual revenue?

Cencora, Inc. (COR) reported $321.3B in total revenue for fiscal year 2025. This represents a 9.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cencora, Inc.'s revenue growing?

Cencora, Inc. (COR) revenue grew by 9.3% year-over-year, from $294.0B to $321.3B in fiscal year 2025.

Is Cencora, Inc. profitable?

Yes, Cencora, Inc. (COR) reported a net income of $1.6B in fiscal year 2025, with a net profit margin of 0.5%.

What is Cencora, Inc.'s EBITDA?

Cencora, Inc. (COR) had EBITDA of $3.7B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cencora, Inc. have?

As of fiscal year 2025, Cencora, Inc. (COR) had $4.4B in cash and equivalents against $7.5B in long-term debt.

What is Cencora, Inc.'s gross margin?

Cencora, Inc. (COR) had a gross margin of 3.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Cencora, Inc.'s operating margin?

Cencora, Inc. (COR) had an operating margin of 0.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Cencora, Inc.'s net profit margin?

Cencora, Inc. (COR) had a net profit margin of 0.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Cencora, Inc. pay dividends?

Yes, Cencora, Inc. (COR) paid $2.20 per share in dividends during fiscal year 2025.

What is Cencora, Inc.'s return on equity (ROE)?

Cencora, Inc. (COR) has a return on equity of 103.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Cencora, Inc.'s free cash flow?

Cencora, Inc. (COR) generated $3.2B in free cash flow during fiscal year 2025. This represents a 7.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Cencora, Inc.'s operating cash flow?

Cencora, Inc. (COR) generated $3.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Cencora, Inc.'s total assets?

Cencora, Inc. (COR) had $76.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Cencora, Inc.'s capital expenditures?

Cencora, Inc. (COR) invested $668.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Cencora, Inc. buy back shares?

Yes, Cencora, Inc. (COR) spent $435.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Cencora, Inc. have outstanding?

Cencora, Inc. (COR) had 194M shares outstanding as of fiscal year 2025.

What is Cencora, Inc.'s current ratio?

Cencora, Inc. (COR) had a current ratio of 0.90 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Cencora, Inc.'s debt-to-equity ratio?

Cencora, Inc. (COR) had a debt-to-equity ratio of 5.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cencora, Inc.'s return on assets (ROA)?

Cencora, Inc. (COR) had a return on assets of 2.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Cencora, Inc.'s P/E ratio?

Cencora, Inc. (COR) trades at 23.1x earnings, its market capitalization divided by net income of $2.6B net income, trailing 12 months to June 30, 2026. The market capitalization is $60.5B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Cencora, Inc.'s price-to-sales ratio?

Cencora, Inc. (COR) trades at 0.2x sales, its market capitalization divided by revenue of $332.8B revenue, trailing 12 months to June 30, 2026. The market capitalization is $60.5B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Cencora, Inc.'s Altman Z-Score?

Cencora, Inc. (COR) has an Altman Z-Score of 4.82, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Cencora, Inc.'s Piotroski F-Score?

Cencora, Inc. (COR) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cencora, Inc.'s earnings high quality?

Cencora, Inc. (COR) has an earnings quality ratio of 2.49x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cencora, Inc. cover its interest payments?

Cencora, Inc. (COR) has an interest coverage ratio of 9.02x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Cencora, Inc.?

Cencora, Inc. (COR) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.